Ascendis Pharma AS Financial Flexibility Index
Ascendis Pharma AS financial flexibility index. Ascendis Pharma AS (A71) has a Financial Flexibility Index of -0.01x as of March 2026. Free cash flow of €-7.72 Million (operating CF €-7.72 Million minus capex €0.00) represents 0% of total liabilities (€1.52 Billion). See Ascendis Pharma AS (A71) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Ascendis Pharma AS (2016–2025)
Financial flexibility index of Ascendis Pharma AS from 2016 to 2025. Historical Financial Flexibility Index trend for Ascendis Pharma AS across 10 annual periods. Check earnings quality score of Ascendis Pharma AS to evaluate the quality of earnings relative to operating cash generation.
Ascendis Pharma AS Financial Flexibility Index by Year (2016–2025)
Ascendis Pharma AS financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Ascendis Pharma AS. For the full cash flow conversion analysis, see cash efficiency ratio of Ascendis Pharma AS.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | €62.38 Million | €53.90 Million | €1.47 Billion | ▲ +118.0% |
| 2024 | -0.24x | €-304.77 Million | €-306.20 Million | €1.29 Billion | ▲ +50.5% |
| 2023 | -0.48x | €-464.92 Million | €-467.36 Million | €971.28 Million | ▲ +17.8% |
| 2022 | -0.58x | €-481.21 Million | €-495.70 Million | €826.39 Million | ▲ +70.2% |
| 2021 | -1.96x | €-393.94 Million | €-417.65 Million | €201.29 Million | ▼ -9.7% |
| 2020 | -1.78x | €-251.69 Million | €-271.55 Million | €141.08 Million | ▲ +16.8% |
| 2019 | -2.14x | €-170.78 Million | €-175.94 Million | €79.62 Million | ▲ +38.7% |
| 2018 | -3.50x | €-136.15 Million | €-138.80 Million | €38.92 Million | ▲ +11.7% |
| 2017 | -3.96x | €-94.16 Million | €-95.10 Million | €23.77 Million | ▲ +10.4% |
| 2016 | -4.42x | €-59.51 Million | €-60.18 Million | €13.46 Million | — |